ABL Attending BARDA Industry Day in DC
Rockville, MD – October 13, 2015 – ABL will have representatives at BARDA Industry Day at the Ronald Reagan Building & International Trade Center in Washington, DC to learn more about BARDA’s key initiatives. We are available to talk to our partners about continuing to provide immunoassay and biomanufacturing support toward developing medical countermeasures. If you are in town for the meeting and would like to set up a visit to our headquarters in Rockville, Maryland or would like to set up a meeting at the conference, please email us.
About ABL, Inc.
ABL, Inc. is a global biomedical contract research and manufacturing organization dedicated to advancing vaccines, therapeutics and other biologic products. ABL has extensive experience working with diverse organizations, including the U.S. Government, biopharmaceutical companies and academic entities. Notable contract manufacturing services include process and assay development, cGMP biologics manufacturing of bulk drug substance, cGMP aseptic fill and finish of drug product, and QC analytics in the U.S. and Europe. ABL also maintains U.S. and European immunological and molecular laboratories to support preclinical and GCLP clinical sample processing and testing. ABL is a part of the Institut Mérieux, a group of companies dedicated to developing translational science for better patient care globally.
For more information visit www.ablinc.com or email us.
